Melanoma: open trials in Singapore

• NCT05727904

  Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  Trial Treatment · Phase 3 · Iovance Biotherapeutics, Inc.

  National Cancer Centre Singapore, Singapore

  Registry updated 2026-09-24

• NCT04198766

  Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  Trial Treatment · Phase 1/2 · Inhibrx Biosciences, Inc

  Icon Cancer Centre Farrer Park, Singapore · Icon Cancer Centre - Mount Alvernia, Singapore · Curie Oncology, Singapore

  Registry updated 2026-07-29

• NCT04986748

  Using QPOP to Predict Treatment for Sarcomas and Melanomas

  Research · National Cancer Centre, Singapore

  National Cancer Centre Singapore, Singapore

  Registry updated 2025-07-01

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error